Study to Assess Safety and Immunogenicity of an Egg-based H5N8 Influenza Vaccine at Multiple Dose Levels Adjuvanted With Matrix-M in Healthy Participants 18 Years of Age and Above.

Clinical trial NCT07779408 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07779408
Sponsor: Sanofi
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Healthy Volunteers Influenza

Start date: 2026-08-10
Primary completion: 2028-02-22
Enrollment: 640

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.